Aurelio Bonavia

1.8k total citations
14 papers, 625 citations indexed

About

Aurelio Bonavia is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Aurelio Bonavia has authored 14 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in Aurelio Bonavia's work include Influenza Virus Research Studies (4 papers), Respiratory viral infections research (3 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Aurelio Bonavia is often cited by papers focused on Influenza Virus Research Studies (4 papers), Respiratory viral infections research (3 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Aurelio Bonavia collaborates with scholars based in United States, Canada and Netherlands. Aurelio Bonavia's co-authors include Pierre J. Talbot, Kathryn V. Holmes, David E. Wentworth, Bruce D. Zelus, Nathalie Arbour, V. Wee Yong, Ganesh Balaratnam, Dale W. Usner, Paul Fredlund and Christopher da Costa and has published in prestigious journals such as Journal of Virology, The Journal of Infectious Diseases and Infection and Immunity.

In The Last Decade

Aurelio Bonavia

14 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aurelio Bonavia United States 8 421 189 148 124 121 14 625
Verena Krähling Germany 17 663 1.6× 198 1.0× 80 0.5× 130 1.0× 113 0.9× 33 799
Meagan Bolles United States 6 600 1.4× 83 0.4× 188 1.3× 112 0.9× 92 0.8× 7 695
W. Widagdo Netherlands 11 635 1.5× 153 0.8× 221 1.5× 147 1.2× 78 0.6× 17 849
Solène Denolly France 11 408 1.0× 116 0.6× 165 1.1× 109 0.9× 51 0.4× 21 602
Benjamin O. Fulton United States 5 685 1.6× 122 0.6× 104 0.7× 218 1.8× 76 0.6× 5 834
Andrew J. Piefer United States 6 446 1.1× 78 0.4× 126 0.9× 156 1.3× 75 0.6× 10 652
Raul Y. Sanchez-David France 7 486 1.2× 110 0.6× 107 0.7× 219 1.8× 182 1.5× 8 705
Panke Qu United States 15 664 1.6× 90 0.5× 121 0.8× 215 1.7× 62 0.5× 15 740
Yíngyún Caì United States 17 485 1.2× 217 1.1× 151 1.0× 165 1.3× 119 1.0× 42 768
Rachel S. Nargi United States 10 840 2.0× 131 0.7× 132 0.9× 316 2.5× 116 1.0× 15 997

Countries citing papers authored by Aurelio Bonavia

Since Specialization
Citations

This map shows the geographic impact of Aurelio Bonavia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurelio Bonavia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurelio Bonavia more than expected).

Fields of papers citing papers by Aurelio Bonavia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurelio Bonavia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurelio Bonavia. The network helps show where Aurelio Bonavia may publish in the future.

Co-authorship network of co-authors of Aurelio Bonavia

This figure shows the co-authorship network connecting the top 25 collaborators of Aurelio Bonavia. A scholar is included among the top collaborators of Aurelio Bonavia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurelio Bonavia. Aurelio Bonavia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bonavia, Aurelio, Micha Levi, Harald Rouha, et al.. (2024). RSM01, a novel respiratory syncytial virus monoclonal antibody: preclinical characterization and results of a first-in-human, randomised clinical trial. BMC Infectious Diseases. 24(1). 1378–1378. 1 indexed citations
2.
Pizzuto, Matteo Samuele, Fabrizia Zatta, Andrea Minola, et al.. (2020). 1231. VIR-2482: A potent and broadly neutralizing antibody for the prophylaxis of influenza A illness. Open Forum Infectious Diseases. 7(Supplement_1). S635–S636. 1 indexed citations
3.
Sager, Jennifer E., David K. Hong, Aurelio Bonavia, et al.. (2020). 631. Preliminary safety and pharmacokinetic profile of VIR-2482: a monoclonal antibody for the prevention of influenza A illness. Open Forum Infectious Diseases. 7(Supplement_1). S376–S376. 2 indexed citations
4.
Laddy, Dominick J., Aurelio Bonavia, Willem A. Hanekom, et al.. (2017). Toward Tuberculosis Vaccine Development: Recommendations for Nonhuman Primate Study Design. Infection and Immunity. 86(2). 24 indexed citations
5.
Costa, Christopher da, Barry Walker, & Aurelio Bonavia. (2015). Tuberculosis Vaccines – state of the art, and novel approaches to vaccine development. International Journal of Infectious Diseases. 32. 5–12. 43 indexed citations
6.
Ramos, Eleanor L., Jennifer L. Mitcham, Aurelio Bonavia, et al.. (2014). Efficacy and Safety of Treatment With an Anti-M2e Monoclonal Antibody in Experimental Human Influenza. The Journal of Infectious Diseases. 211(7). 1038–1044. 109 indexed citations
7.
Bonavia, Aurelio, et al.. (2012). BACTERIA  CRYOPRESERVATION PROTOCOL. Protocol Exchange. 2 indexed citations
8.
Bonavia, Aurelio, et al.. (2012). Virus Cryopreservation Protocol. Protocol Exchange. 1 indexed citations
9.
Wang, Qing-Yin, Simon M. Bushell, Min Qing, et al.. (2011). Inhibition of Dengue Virus through Suppression of Host Pyrimidine Biosynthesis. Journal of Virology. 85(13). 6548–6556. 127 indexed citations
10.
Bonavia, Aurelio, et al.. (2009). Recruitment of the TSG101/ESCRT-I Machinery in Host Cells by Influenza Virus: Implications for Broad-Spectrum Therapy. Antiviral Research. 82(2). A71–A71. 2 indexed citations
11.
12.
Breslin, Jamie J., Mary Smith, Lotte K. Vogel, et al.. (2003). Human Coronavirus 229E: Receptor Binding Domain and Neutralization by Soluble Receptor at 37°C. Journal of Virology. 77(7). 4435–4438. 66 indexed citations
13.
Bonavia, Aurelio, Bruce D. Zelus, David E. Wentworth, Pierre J. Talbot, & Kathryn V. Holmes. (2003). Identification of a Receptor-Binding Domain of the Spike Glycoprotein of Human Coronavirus HCoV-229E. Journal of Virology. 77(4). 2530–2538. 162 indexed citations
14.
Bonavia, Aurelio, Nathalie Arbour, V. Wee Yong, & Pierre J. Talbot. (1997). Infection of primary cultures of human neural cells by human coronaviruses 229E and OC43. Journal of Virology. 71(1). 800–806. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Verena Krähling Breakdown of academic impact, for papers by Meagan Bolles Breakdown of academic impact, for papers by W. Widagdo Breakdown of academic impact, for papers by Solène Denolly Breakdown of academic impact, for papers by Benjamin O. Fulton Breakdown of academic impact, for papers by Andrew J. Piefer Breakdown of academic impact, for papers by Raul Y. Sanchez-David Breakdown of academic impact, for papers by Panke Qu Breakdown of academic impact, for papers by Yíngyún Caì Breakdown of academic impact, for papers by Rachel S. Nargi
Rankless by CCL
2026